Magnetar AI Ventures — 2026 Investments
1 investments dated 2026 · listed companies and verified rows first · show all
Enable Injections develops and manufactures enFuse, a wearable drug delivery device that delivers large volumes of pharmaceutical and biologic therapeutics subcutaneously for patients with chronic diseases.
BiotechHealthtechMedical DevicesCincinnati, US
Mike Hooven(Chairman, President and CEO)inTimothy Flaherty(Executive Officer)Simone Song(Director)Karen Robards(Director)Richard J D'Augustine(Director)Norman R. Weldon(Director)
Board seatErik Falk· per SEC Form D · $30M raise · filed Jan 2026
Co-investorsAngel Physicians FundCincyTechLightship CapitalOhio Innovation FundVersant Ventures
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.